- Home
- HBB vs AVR Comparison
HBB vs AVR Comparison
Compare HBB & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- AVR
- Stock Information
- Founded
- HBB 1904
- AVR 1999
- Country
- HBB United States
- AVR Australia
- Employees
- HBB N/A
- AVR N/A
- Industry
- HBB Home Furnishings
- AVR
- Sector
- HBB Consumer Discretionary
- AVR
- Exchange
- HBB Nasdaq
- AVR NYSE
- Market Cap
- HBB 230.7M
- AVR 215.6M
- IPO Year
- HBB 2017
- AVR 2024
- Fundamental
- Price
- HBB $16.47
- AVR $6.18
- Analyst Decision
- HBB
- AVR Strong Buy
- Analyst Count
- HBB 0
- AVR 4
- Target Price
- HBB N/A
- AVR $16.50
- AVG Volume (30 Days)
- HBB 38.1K
- AVR 156.0K
- Earning Date
- HBB 03-05-2025
- AVR 01-01-0001
- Dividend Yield
- HBB 2.79%
- AVR N/A
- EPS Growth
- HBB 107.04
- AVR N/A
- EPS
- HBB 1.88
- AVR N/A
- Revenue
- HBB $647,834,000.00
- AVR $2,826,588.00
- Revenue This Year
- HBB $4.60
- AVR N/A
- Revenue Next Year
- HBB N/A
- AVR N/A
- P/E Ratio
- HBB $8.63
- AVR N/A
- Revenue Growth
- HBB 5.30
- AVR N/A
- 52 Week Low
- HBB $14.34
- AVR $5.10
- 52 Week High
- HBB $31.78
- AVR $6.29
- Technical
- Relative Strength Index (RSI)
- HBB 36.77
- AVR N/A
- Support Level
- HBB $17.23
- AVR N/A
- Resistance Level
- HBB $18.11
- AVR N/A
- Average True Range (ATR)
- HBB 0.72
- AVR 0.00
- MACD
- HBB 0.04
- AVR 0.00
- Stochastic Oscillator
- HBB 24.00
- AVR 0.00
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.